HC006 with a PD-1 inhibitor for advanced solid tumors
Treatments studied
Part of Cancer clinical trials.
This trial tests a new drug called HC006 combined with a standard immunotherapy (PD-1 inhibitor) for people with advanced solid tumors. It aims to see if the combination is safe and effective.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have an advanced solid tumor that has been confirmed by a biopsy.
- You have a tumor sample (stored or new) that can be tested.
- Your tumor can be measured on a scan (not counting brain tumors).
- You are active enough to do light daily activities (ECOG 0 or 1).
- Your cancer has not spread to the brain, spinal cord, or the lining of the brain.
- You agree to use effective birth control (if applicable) during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new drug called HC006 for advanced solid tumors that no longer respond to standard treatments. It aims to find a safe dose and see if it helps shrink tumors.
This trial tests a new drug called HC010 as a first treatment for people with advanced non-small cell lung cancer that is PD-L1 positive. It aims to see if the drug can help shrink or control the cancer.
This trial tests a new drug called FH-006 for people with advanced solid tumors that cannot be surgically removed or have spread. It aims to see if the drug is safe and effective.
This trial tests a new combination treatment called HS-20089 for people with advanced solid tumors. The goal is to see if it is safe and how well it works against cancer that has not responded to other treatments.
This study tests a new combination drug called HS-20093 for people with advanced solid tumors. It aims to see if it is safe and works against cancer that hasn't responded to other treatments.
This trial tests a new drug called HDM2006 for people with advanced solid tumors that have not responded to standard treatments. The goal is to see if the drug is safe and effective.
Hear when a new Advanced Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.